Log in to save to my catalogue

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early acce...

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early acce...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e4409de6829f4829bf3c1080ab58ca37

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

About this item

Full title

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

Publisher

England: BioMed Central Ltd

Journal title

BMC pulmonary medicine, 2017-12, Vol.17 (1), p.216-216, Article 216

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Following positive results from the Phase III CHEST-1 study in patients with inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH), the Phase IIIb CTEPH early access study (EAS) was designed to assess the safety and tolerability of riociguat in real-world clinical practice, as well as to provide patients with earl...

Alternative Titles

Full title

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e4409de6829f4829bf3c1080ab58ca37

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e4409de6829f4829bf3c1080ab58ca37

Other Identifiers

ISSN

1471-2466

E-ISSN

1471-2466

DOI

10.1186/s12890-017-0563-7

How to access this item